Income Statement Vaxcyte, Inc.

Stocks

PCVX

US92243G1085

Biotechnology & Medical Research

Real-time Estimate Cboe BZX Other stock markets 12:16:49 11/06/2026 am IST			5-day change	1st Jan Change
45.69 ^USD	-2.54%		-2.17%	-0.50%

03/06	Vaxcyte Doses First Participant in Phase 1 Trial of Group A Strep Vaccine Candidate VAX-A1	MT
03/06	Vaxcyte Doses First Participant In Phase 1 Study Evaluating VAX-A1 For The Prevention Of Disease Caused By Group A Streptococcus In Healthy Adults	CI

24501c52100c45dd8e2ec9c92f977a.PQp8QAnfrvDuhKN9ZDMvR1hSTjKc3VioefAhK3zRllE.SFgfOEKnl8SvtOQvKERcLihkAECpqTnQKqFyGiSioiUPQzo3U4_jyY30zA

Published financial data: VAXCYTE, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Cost of Goods Sold, Total	-	2.3Cr	7.5Cr	-	-
Gross Profit	-	-2.3Cr	-7.5Cr	-	-
Selling General & Admin Expenses, Total	2.53Cr	3.98Cr	6.07Cr	9.29Cr	13Cr
R&D Expenses	7.84Cr	17Cr	33Cr	48Cr	79Cr
Other Operating Expenses, Total	10Cr	21Cr	39Cr	57Cr	92Cr
Operating Income	-10Cr	-23Cr	-47Cr	-57Cr	-92Cr
Interest Expense, Total	-7T	-2T	-	-	-
Interest And Investment Income	3L	83.56L	6.29Cr	11Cr	12Cr
Net Interest Expenses	3L	83.54L	6.29Cr	11Cr	12Cr
Currency Exchange Gains (Loss)	16.69L	-14.7L	-18.97L	-	-
Other Non Operating Income (Expenses)	15.85L	19.31L	47.65L	-43.75L	3.73Cr
EBT, Excl. Unusual Items	-10Cr	-22Cr	-40Cr	-46Cr	-77Cr
Gain (Loss) On Sale Of Investments	2T	-	-	-	-
Gain (Loss) On Sale Of Assets	-	-44T	-	-	-
Legal Settlements	-	-	-	-	-
Other Unusual Items	-	-	-	-	-
EBT, Incl. Unusual Items	-10Cr	-22Cr	-40Cr	-46Cr	-77Cr
Earnings From Continuing Operations	-10Cr	-22Cr	-40Cr	-46Cr	-77Cr
Net Income to Company	-10Cr	-22Cr	-40Cr	-46Cr	-77Cr
Net Income - (IS)	-10Cr	-22Cr	-40Cr	-46Cr	-77Cr
Net Income to Common Incl Extra Items	-10Cr	-22Cr	-40Cr	-46Cr	-77Cr
Net Income to Common Excl. Extra Items	-10Cr	-22Cr	-40Cr	-46Cr	-77Cr
Per Share Items
Net EPS - Basic	-1.93	-3.44	-4.14	-3.8	-5.63
Basic EPS - Continuing Operations	-1.93	-3.44	-4.14	-3.8	-5.63
Basic Weighted Average Shares Outstanding	5.19Cr	6.49Cr	9.72Cr	12Cr	14Cr
Net EPS - Diluted	-1.93	-3.44	-4.14	-3.8	-5.63
Diluted EPS - Continuing Operations	-1.93	-3.44	-4.14	-3.8	-5.63
Diluted Weighted Average Shares Outstanding	5.19Cr	6.49Cr	9.72Cr	12Cr	14Cr
Normalized Basic EPS	-1.2	-2.15	-2.59	-2.38	-3.52
Normalized Diluted EPS	-1.2	-2.15	-2.59	-2.38	-3.52
Supplemental Items
EBITDA	-10Cr	-23Cr	-46Cr	-56Cr	-91Cr
EBITA	-10Cr	-23Cr	-47Cr	-57Cr	-92Cr
EBIT	-10Cr	-23Cr	-47Cr	-57Cr	-92Cr
EBITDAR	-9.87Cr	-22Cr	-46Cr	-55Cr	-89Cr
Normalized Net Income	-6.25Cr	-14Cr	-25Cr	-29Cr	-48Cr
Interest on Long-Term Debt	7T	2T	-	-	-
Supplemental Operating Expense Items
General and Administrative Expenses	2.53Cr	3.98Cr	6.07Cr	9.29Cr	13Cr
Research And Development Expense From Footnotes	7.84Cr	17Cr	33Cr	48Cr	79Cr
Net Rental Expense, Total	32L	79L	85L	1.15Cr	1.54Cr
Imputed Operating Lease Interest Expense	-	7.27T	-	-	-
Imputed Operating Lease Depreciation	-	78.93L	-	-	-
Stock-Based Comp., R&D Exp. (Total)	39.54L	98.99L	2.33Cr	4.28Cr	7.41Cr
Stock-Based Comp., G&A Exp. (Total)	67.75L	1.38Cr	2.55Cr	4.2Cr	6.48Cr
Total Stock-Based Compensation	1.07Cr	2.36Cr	4.88Cr	8.48Cr	14Cr

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	6.9Cr	83Cr	40Cr	39Cr	17Cr
Short Term Investments	18Cr	9.67Cr	68Cr	135.93Cr	138.7Cr
Total Cash And Short Term Investments	25Cr	93Cr	108.02Cr	174.72Cr	156.1Cr
Other Receivables	12L	10L	36.07L	2.07Cr	4.66Cr
Total Receivables	12L	10L	36.07L	2.07Cr	4.66Cr
Prepaid Expenses	91.78L	1.02Cr	61.59L	1.57Cr	1.7Cr
Other Current Assets, Total	-	-	59.61L	43.83L	28.02L
Total Current Assets	26Cr	94Cr	109.6Cr	178.8Cr	162.74Cr
Gross Property Plant And Equipment	4.11Cr	3.78Cr	12Cr	29Cr	41Cr
Accumulated Depreciation	-52.05L	-61.17L	-92.72L	-1.63Cr	-3.28Cr
Net Property Plant And Equipment	3.59Cr	3.16Cr	11Cr	27Cr	37Cr
Long-term Investments	2.71Cr	2.65Cr	16Cr	138.75Cr	88Cr
Deferred Charges Long-Term	5L	-	-	-	-
Other Long-Term Assets, Total	44.6L	54.26L	3.87Cr	6.57Cr	12Cr
Total Assets	32Cr	100.62Cr	140.79Cr	351.13Cr	300.27Cr
Liabilities
Accounts Payable, Total	67.58L	97.95L	1.46Cr	4.85Cr	7.09Cr
Accrued Expenses, Total	1.67Cr	2.48Cr	12Cr	8.58Cr	13Cr
Current Portion of Leases	52.76L	59.1L	71.13L	58.91L	61.24L
Other Current Liabilities	-	-	-	-	-
Total Current Liabilities	2.87Cr	4.05Cr	15Cr	14Cr	21Cr
Long-Term Debt	-	-	-	-	-
Long-Term Leases	1.15Cr	1.2Cr	2.21Cr	6.52Cr	11Cr
Other Non Current Liabilities	96T	9T	-	1L	1L
Total Liabilities	4.03Cr	5.26Cr	17Cr	21Cr	32Cr
Preferred Stock Convertible	-	-	-	-	-
Preferred Stock - Others	-	-	-	-	-
Total Preferred Equity	-	-	-	-	-
Common Stock, Total	56T	82T	98T	1L	1L
Additional Paid In Capital	58Cr	147.6Cr	216.46Cr	469.79Cr	483.87Cr
Retained Earnings	-30Cr	-52Cr	-92Cr	-138.83Cr	-215.49Cr
Comprehensive Income and Other	-2L	-4L	2L	-38.73L	15.87L
Total Common Equity	28Cr	95Cr	124.05Cr	330.58Cr	268.55Cr
Total Equity	28Cr	95Cr	124.05Cr	330.58Cr	268.55Cr
Total Liabilities And Equity	32Cr	100.62Cr	140.79Cr	351.13Cr	300.27Cr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	5.63Cr	8Cr	11Cr	13Cr	14Cr
ECS Total Common Shares Outstanding	5.3Cr	7.95Cr	9.54Cr	12Cr	13Cr
Book Value / Share	5.36	12	13.01	26.47	20.49
Tangible Book Value	28Cr	95Cr	124.05Cr	330.58Cr	268.55Cr
Tangible Book Value Per Share	5.36	12	13.01	26.47	20.49
Total Debt	1.68Cr	1.79Cr	2.92Cr	7.11Cr	12Cr
Net Debt	-23Cr	-91Cr	-105.1Cr	-167.61Cr	-144.35Cr
Debt Equivalent Oper. Leases	2.56Cr	6.32Cr	6.8Cr	9.2Cr	12Cr
Account Code - Inventory Valuation	3	3	3	3	3
Machinery, Total	1.15Cr	1.51Cr	3.56Cr	5.82Cr	6.58Cr
Full Time Employees	89	158	254	414	507
Assets under Capital Lease - Gross	-	-	-	-	-

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	-10Cr	-22Cr	-40Cr	-46Cr	-77Cr
Depreciation & Amortization - CF	34.57L	91.96L	1.02Cr	1.58Cr	2.49Cr
Depreciation & Amortization, Total	34.57L	91.96L	1.02Cr	1.58Cr	2.49Cr
(Gain) Loss From Sale Of Asset	97T	44T	-	-	-
(Gain) Loss on Sale of Investments - (CF)	14.06L	-9L	-3.48Cr	-3.87Cr	-1.44Cr
Asset Writedown & Restructuring Costs	-	2L	-	-	-
Stock-Based Compensation (CF)	1.07Cr	2.36Cr	4.88Cr	8.48Cr	14Cr
Other Operating Activities, Total	-	79.95L	-	42.32L	-3.48Cr
Change In Accounts Payable	-1.25Cr	28.96L	1.12Cr	3.46Cr	1.99Cr
Change in Other Net Operating Assets	-2.45Cr	98.41L	7.01Cr	-8.95Cr	-2.34Cr
Cash from Operations	-12Cr	-17Cr	-30Cr	-45Cr	-66Cr
Capital Expenditure	-65.55L	-58.48L	-6.79Cr	-12Cr	-5.7Cr
Sale of Property, Plant, and Equipment	26T	7T	-	-	-
Investment in Marketable and Equity Securities, Total	-21Cr	8.04Cr	-71Cr	-188.65Cr	49Cr
Cash from Investing	-21Cr	7.46Cr	-77Cr	-200.57Cr	44Cr
Long-Term Debt Repaid, Total	-	-	-	-	-
Total Debt Repaid	-	-	-	-	-
Issuance of Common Stock	1.78Cr	86Cr	64Cr	246.28Cr	1.3Cr
Repurchase of Common Stock	-	-	-	-1.43Cr	-1.1Cr
Issuance of Preferred Stock	-	-	-	-	-
Other Financing Activities, Total	-	-9L	-38.76L	-	-
Cash from Financing	1.78Cr	86Cr	64Cr	244.85Cr	20.14L
Foreign Exchange Rate Adjustments	-4L	1L	-66.86L	4L	24.39L
Net Change in Cash	-32Cr	77Cr	-44Cr	-93.59L	-21Cr
Supplemental Items
Cash Interest Paid	7T	2T	-	-	-
Levered Free Cash Flow	-8.82Cr	-11Cr	-20Cr	-40Cr	-43Cr
Unlevered Free Cash Flow	-8.82Cr	-11Cr	-20Cr	-40Cr	-43Cr
Change In Net Working Capital	3.1Cr	-1.04Cr	-9.91Cr	2.9Cr	-3.97Cr
Net Debt Issued / Repaid	-	-	-	-	-

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	-18.07	-21.82	-24.23	-14.47	-17.72
Return on Total Capital	-20.04	-22.82	-26.1	-15.32	-18.68
Return On Equity %	-31.78	-36.11	-36.67	-20.41	-25.59
Return on Common Equity	-31.78	-36.11	-36.67	-20.41	-25.59
Short Term Liquidity
Current Ratio	8.93	23.26	7.54	12.75	7.91
Quick Ratio	8.61	23.01	7.46	12.61	7.81
Operating Cash Flow to Current Liabilities	-4.23	-4.21	-2.04	-3.23	-3.19
Average Days Payable Outstanding	-	131.37	59.33	-	-
Long Term Solvency
Total Debt/Equity	5.91	1.88	2.36	2.15	4.37
Total Debt / Total Capital	5.58	1.85	2.3	2.11	4.19
LT Debt/Equity	4.05	1.26	1.78	1.97	4.15
Long-Term Debt / Total Capital	3.83	1.24	1.74	1.93	3.97
Total Liabilities / Total Assets	12.43	5.22	11.89	5.85	10.56
EBIT / Interest Expense	-14.81T	-1L	-	-	-
EBITDA / Interest Expense	-14.1T	-1L	-	-	-
(EBITDA - Capex) / Interest Expense	-15.03T	-1L	-	-	-
Total Debt / EBITDA	-0.17	-0.08	-0.06	-0.13	-0.13
Net Debt / EBITDA	2.32	4.12	2.3	3.04	1.62
Total Debt / (EBITDA - Capex)	-0.16	-0.08	-0.06	-0.11	-0.12
Net Debt / (EBITDA - Capex)	2.18	4.01	2	2.5	1.52
Growth Over Prior Year
Gross Profit, 1 Yr. Growth %	-	-	226.16	-	-
EBITDA, 1 Yr. Growth %	15.53	125.46	102.41	21.01	61.28
EBITA, 1 Yr. Growth %	15.73	124.03	101.52	21.69	62.18
EBIT, 1 Yr. Growth %	15.73	124.03	101.52	21.69	62.18
Earnings From Cont. Operations, 1 Yr. Growth %	12.17	123.31	80	15.33	65.25
Net Income, 1 Yr. Growth %	12.17	123.31	80	15.33	65.25
Normalized Net Income, 1 Yr. Growth %	12.17	123.26	80.03	15.33	65.25
Diluted EPS Before Extra, 1 Yr. Growth %	-36.17	78.72	20.19	-8.15	48.14
Net Property, Plant and Equip., 1 Yr. Growth %	997.56	-11.87	249.54	144.2	38.21
Total Assets, 1 Yr. Growth %	-17.44	210.23	39.93	149.4	-14.48
Tangible Book Value, 1 Yr. Growth %	-17.88	235.76	30.08	166.5	-18.76
Common Equity, 1 Yr. Growth %	-17.88	235.76	30.08	166.5	-18.76
Cash From Operations, 1 Yr. Growth %	160.34	40.53	73.97	52.51	44.84
Capital Expenditures, 1 Yr. Growth %	467.53	-10.79	1.06T	75.55	-52.19
Levered Free Cash Flow, 1 Yr. Growth %	512.43	22.26	87.78	99.32	6.79
Unlevered Free Cash Flow, 1 Yr. Growth %	512.58	22.27	87.78	99.32	6.79
Compound Annual Growth Rate Over Two Years
EBITDA, 2 Yr. CAGR %	38.74	61.39	113.62	56.59	39.7
EBITA, 2 Yr. CAGR %	38.36	61.02	112.48	56.6	40.48
EBIT, 2 Yr. CAGR %	38.36	61.02	112.48	56.6	40.48
Earnings From Cont. Operations, 2 Yr. CAGR %	41.09	58.27	100.49	44.08	38.05
Net Income, 2 Yr. CAGR %	41.09	58.27	100.49	44.08	38.05
Normalized Net Income, 2 Yr. CAGR %	36.82	58.26	100.49	44.08	38.05
Diluted EPS Before Extra, 2 Yr. CAGR %	-61.86	6.81	46.56	5.07	16.64
Net Property, Plant and Equip., 2 Yr. CAGR %	225.43	211	75.51	192.16	83.72
Total Assets, 2 Yr. CAGR %	122.19	60.04	108.35	86.81	46.04
Tangible Book Value, 2 Yr. CAGR %	63.4	66.05	108.99	86.19	47.14
Common Equity, 2 Yr. CAGR %	63.4	66.05	108.99	86.19	47.14
Cash From Operations, 2 Yr. CAGR %	60.46	91.28	56.36	62.89	48.62
Capital Expenditures, 2 Yr. CAGR %	134.21	125.02	221.79	351.67	-8.38
Levered Free Cash Flow, 2 Yr. CAGR %	70.46	173.64	51.52	93.7	45.9
Unlevered Free Cash Flow, 2 Yr. CAGR %	70.52	173.68	51.53	93.7	45.9
Compound Annual Growth Rate Over Three Years
EBITDA, 3 Yr. CAGR %	43.47	63.12	74.05	76.75	58.14
EBITA, 3 Yr. CAGR %	42.89	62.47	73.52	76.45	58.43
EBIT, 3 Yr. CAGR %	42.89	62.47	73.52	76.45	58.43
Earnings From Cont. Operations, 3 Yr. CAGR %	50.28	64.43	65.2	66.74	50.82
Net Income, 3 Yr. CAGR %	50.28	64.43	65.2	66.74	50.82
Normalized Net Income, 3 Yr. CAGR %	42.39	61.08	65.2	66.74	50.82
Diluted EPS Before Extra, 3 Yr. CAGR %	-38.09	-36.17	11.1	25.42	17.82
Net Property, Plant and Equip., 3 Yr. CAGR %	119.17	110.54	223.35	95.94	127.65
Total Assets, 3 Yr. CAGR %	66.08	148.34	53.04	121.22	43.97
Tangible Book Value, 3 Yr. CAGR %	70.08	107.74	53.07	126.63	41.22
Common Equity, 3 Yr. CAGR %	70.08	107.74	53.07	126.63	41.22
Cash From Operations, 3 Yr. CAGR %	58.54	53.52	85.33	55.07	56.63
Capital Expenditures, 3 Yr. CAGR %	54.6	69.78	288.79	162.94	113.66
Levered Free Cash Flow, 3 Yr. CAGR %	63.49	52.58	141.36	66.02	58.83
Unlevered Free Cash Flow, 3 Yr. CAGR %	63.61	52.62	141.39	66.03	58.83
Compound Annual Growth Rate Over Five Years
EBITDA, 5 Yr. CAGR %	-	67.91	68.23	60.44	59.4
EBITA, 5 Yr. CAGR %	-	67.09	67.47	60.1	59.46
EBIT, 5 Yr. CAGR %	-	67.09	67.47	60.1	59.46
Earnings From Cont. Operations, 5 Yr. CAGR %	-	66.94	68.65	55.96	53.75
Net Income, 5 Yr. CAGR %	-	66.94	68.65	55.96	53.75
Normalized Net Income, 5 Yr. CAGR %	-	66.09	63.28	54.06	53.75
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-6.56	-12.61	-22.09	13.28
Net Property, Plant and Equip., 5 Yr. CAGR %	-	60.49	100.54	140.02	157.91
Total Assets, 5 Yr. CAGR %	-	90.95	81.85	121.61	50.2
Tangible Book Value, 5 Yr. CAGR %	-	100.91	84.69	98.83	50.67
Common Equity, 5 Yr. CAGR %	-	100.91	84.69	98.83	50.67
Cash From Operations, 5 Yr. CAGR %	-	62.7	57.66	57.2	69.67
Capital Expenditures, 5 Yr. CAGR %	-	36.77	107.28	151.05	118.08
Levered Free Cash Flow, 5 Yr. CAGR %	-	-	58.59	67.78	97.34
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-	58.66	67.81	97.35